| Dr Toya Hester Kelley, MD | |
|
1120 15th St, Augusta, GA 30912-0004 | |
| (706) 721-3157 | |
| Not Available |
| Full Name | Dr Toya Hester Kelley |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 1120 15th St, Augusta, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003013368 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 002427 (Georgia) | Primary |
| 207Q00000X | Family Medicine | 63674 (Georgia) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Toya Hester Kelley, MD 1120 15th Street, Augusta, GA 30912-0004 Ph: (706) 721-3157 | Dr Toya Hester Kelley, MD 1120 15th St, Augusta, GA 30912-0004 Ph: (706) 721-3157 |
News Archive
Just in time for American Heart Month, Vanderbilt Heart and Vascular Institute is offering a new blood test that can predict if a patient is at high risk for heart disease. Vanderbilt is among the first institutions in the country, and the only one in Tennessee, to offer this test.
Eighteen years ago, orthopedic surgeon William Bargar, M.D. made history when, at Sutter General Hospital in Sacramento, he performed the first-ever hip replacement using a robotic device he developed called ROBODOC®, which improves precision in joint replacement surgery. Warren Roberts of Davis was among Dr. Bargar's first patients; in 1995, he underwent replacement of his left hip as a part of an FDA study using ROBODOC®.
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) has announced that its clinical trial application (CTA) for ANAVEX 2-73, the company's lead compound for Alzheimer's disease, has been approved by the German regulatory health authority, BfArM. The Phase I trial of ANAVEX 2-73, which includes testing in healthy human volunteers, will commence immediately. In this Phase I program Anavex will assess the safety, maximally tolerated dose, pharmacokinetics and pharmacodynamics of ANAVEX 2-73.
University of Maryland School of Medicine researchers have identified two genes associated with binge drinking that may open doors to new, more effective treatments for excessive alcohol drinking. The scientists found that manipulating two receptors in the brain, GABA receptors and toll-like receptor 4 (TLR4), "caused profound reduction" of binge drinking for two weeks in rodents that had been bred and trained to drink excessively. The study was published online the week of Feb. 28 in the journal the Proceedings of the National Academy of Sciences.
› Verified 4 days ago
Dr. Daria Ravangard, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-6569 | |
Janis S. Coffin, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-4588 Fax: 706-721-7264 | |
Dr. William Robert Rout, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 963 Bennock Mill Dr., Augusta, GA 30906 Phone: 352-538-5899 | |
Racquel Puranda, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 678-790-0634 | |
Angela Overstreet Wright, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2607 Commons Blvd, Augusta, GA 30909 Phone: 706-750-8601 | |
Shahed Anam Ibn Faruk, Family Medicine Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-2273 |